Total Payments
$44,303
2024 Payments
$3,555
Companies
15
Transactions
83
Medicare Patients
1,353
Medicare Billing
$219,471
Payment Breakdown by Category
Consulting$32,790 (74.0%)
Travel$4,379 (9.9%)
Other$4,338 (9.8%)
Food & Beverage$2,786 (6.3%)
Education$10.87 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,790 | 14 | 74.0% |
| Travel and Lodging | $4,379 | 18 | 9.9% |
| Honoraria | $4,338 | 2 | 9.8% |
| Food and Beverage | $2,786 | 48 | 6.3% |
| Education | $10.87 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $11,621 | 22 | $0 (2020) |
| Genentech, Inc. | $6,461 | 9 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $6,237 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,676 | 12 | $0 (2023) |
| Gilead Sciences, Inc. | $4,777 | 12 | $0 (2018) |
| Innate Pharma, Inc | $2,400 | 1 | $0 (2020) |
| BeiGene USA, Inc. | $2,250 | 1 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $1,938 | 1 | $0 (2020) |
| Genentech USA, Inc. | $1,885 | 4 | $0 (2019) |
| BeiGene, Ltd. | $450.00 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,555 | 10 | BeiGene USA, Inc. ($2,250) |
| 2023 | $1,592 | 16 | AstraZeneca Pharmaceuticals LP ($1,089) |
| 2022 | $4,187 | 5 | Genentech, Inc. ($2,522) |
| 2021 | $4,463 | 2 | AstraZeneca Pharmaceuticals LP ($4,453) |
| 2020 | $10,628 | 10 | Pharmacyclics LLC, An AbbVie Company ($3,091) |
| 2019 | $4,785 | 8 | Janssen Scientific Affairs, LLC ($4,668) |
| 2018 | $11,493 | 24 | Pharmacyclics LLC, An AbbVie Company ($5,058) |
| 2017 | $3,599 | 8 | Pharmacyclics LLC, An AbbVie Company ($3,473) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2024 | Genentech, Inc. | Columvi (Biological) | Food and Beverage | In-kind items and services | $43.60 | General |
| Category: BioOncology | ||||||
| 10/16/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $23.60 | General |
| 05/29/2024 | Genentech, Inc. | Columvi (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: BioOncology | ||||||
| 04/06/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $83.91 | General |
| Category: Oncology | ||||||
| 04/04/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Oncology | ||||||
| 04/03/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $162.83 | General |
| 04/03/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $13.54 | General |
| 03/19/2024 | Janssen Scientific Affairs, LLC | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Oncology | ||||||
| 02/21/2024 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| 02/21/2024 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $312.50 | General |
| 12/10/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $142.71 | General |
| 12/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 12/09/2023 | Genentech, Inc. | Columvi (Biological) | Food and Beverage | In-kind items and services | $147.76 | General |
| Category: BioOncology | ||||||
| 12/08/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 12/08/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Oncology | ||||||
| 10/13/2023 | Genentech, Inc. | Columvi (Biological) | Food and Beverage | In-kind items and services | $39.05 | General |
| Category: BioOncology | ||||||
| 10/08/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $129.54 | General |
| Category: Oncology | ||||||
| 04/06/2023 | Janssen Scientific Affairs, LLC | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Oncology | ||||||
| 03/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $73.61 | General |
| 03/09/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $73.61 | General |
| 03/09/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $72.17 | General |
| 03/09/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $2.30 | General |
| 03/08/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $72.17 | General |
| 03/08/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $70.72 | General |
| 03/08/2023 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $70.06 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 349 | 525 | $159,611 | $40,267 |
| 2022 | 6 | 260 | 466 | $115,362 | $42,191 |
| 2021 | 8 | 319 | 667 | $146,341 | $65,753 |
| 2020 | 11 | 425 | 837 | $168,087 | $71,261 |
Total Patients
1,353
Total Services
2,495
Medicare Billing
$219,471
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 131 | 206 | $59,442 | $14,985 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 58 | 92 | $38,915 | $9,760 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 92 | 116 | $22,954 | $5,097 | 22.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 38 | 38 | $20,216 | $4,930 | 24.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 46 | $12,888 | $3,909 | 30.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 27 | $5,196 | $1,585 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 109 | 176 | $46,208 | $13,050 | 28.2% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2022 | 25 | 76 | $12,160 | $12,139 | 99.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 86 | $21,672 | $6,763 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 21 | 35 | $13,405 | $4,070 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 65 | 76 | $13,596 | $3,903 | 28.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $8,321 | $2,266 | 27.2% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2021 | 29 | 173 | $27,680 | $27,728 | 100.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 122 | 216 | $49,098 | $15,850 | 32.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 34 | 57 | $18,744 | $6,826 | 36.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 71 | $17,822 | $5,981 | 33.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 54 | 72 | $10,910 | $3,605 | 33.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 16 | 16 | $7,232 | $2,408 | 33.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 33 | 41 | $8,489 | $1,931 | 22.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 17 | 21 | $6,366 | $1,426 | 22.4% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2020 | 31 | 196 | $31,360 | $31,349 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 115 | 219 | $44,559 | $13,209 | 29.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 58 | 93 | $26,653 | $8,041 | 30.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 23 | 75 | $18,750 | $6,480 | 34.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 73 | 109 | $18,807 | $4,540 | 24.1% |
About Dr. Stephen Spurgeon, MD
Dr. Stephen Spurgeon, MD is a Internal Medicine healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194730606.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Spurgeon, MD has received a total of $44,303 in payments from pharmaceutical and medical device companies, with $3,555 received in 2024. These payments were reported across 83 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($32,790).
As a Medicare-enrolled provider, Spurgeon has provided services to 1,353 Medicare beneficiaries, totaling 2,495 services with total Medicare billing of $219,471. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Portland, OR
- Active Since 07/31/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194730606
Products in Payments
- Imbruvica (Drug) $11,621
- IMBRUVICA (Drug) $6,237
- CALQUENCE (Drug) $4,588
- Non-Covered Product (Drug) $2,750
- BRUKINSA (Drug) $2,700
- Lumoxiti (Drug) $2,400
- XPOVIO (Drug) $1,938
- Rituxan (Biological) $1,642
- Columvi (Biological) $250.81
- Epkinly (Drug) $154.21
- VENCLEXTA (Biological) $126.31
- ADCETRIS (Biological) $83.91
- TIBSOVO (Drug) $17.29
- KEYTRUDA (Biological) $10.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Portland
Nananda Col, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Stephen Yau, M.d, M.D
Internal Medicine — Payments: $980,262
Internal Medicine $980,262
Ethan Korngold, Md, MD
Internal Medicine — Payments: $610,759
Internal Medicine $610,759
Dr. Firas Zahr, Md, MD
Internal Medicine — Payments: $543,624
Internal Medicine $543,624
Dr. Martin Moehlen, M.d, M.D
Internal Medicine — Payments: $318,908
Internal Medicine $318,908
Scott Chadderdon, Md, MD
Internal Medicine — Payments: $189,078
Internal Medicine $189,078